News

media

Apr 1, 2023

Drug Discovery World

The Nobel Prize winning power of click chemistry

publication

Mar 29, 2023

Pre print

SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species

media

Mar 1, 2023

Pharma's Almanac

What do you view as the most disruptive or transformational technology or development on the horizon?

media

Mar 1, 2023

Life Science Leader

Translating Nobel Prize Winning Science Into Medicine

media

Feb 8, 2023

The Bio Report

A Company That Bets Its Therapies Will Click with Patients

media

Jan 12, 2023

Healio

Nobel laureate takes pride in success of bioorthogonal chemistry for cancer treatment

media

Dec 2, 2022

SF Business Times

The Long Game, Nobel Prize winners pay it forward

conference

Nov 7, 2022

2022 - SITC - SQ3370 Poster

Treatment with SQ3370, a doxorubicin-based click chemistry therapeutic, promotes immune activation in the tumor microenvironment

conference

Nov 7, 2022

2022 - SITC - SQ2270 Poster

SQ2270, a Novel MMAE-based Click Chemistry Therapeutic, Promotes Tumor Growth Inhibition and Extensive Immune Cell Infiltration in the RENCA Cancer Model

media

Nov 2, 2022

Drug Discovery & Development

Click chemistry company Shasqi has a link to the Nobel Prize in Chemistry

media

Oct 27, 2022

PharmaVoice

The first company to use Nobel-winning click chemistry in humans is on a mission to transform oncology

conference

Oct 17, 2022

2022 - AACR - Tumor IO

Combining SQ3370, a Doxorubicin-based Therapeutic, with TLR and STING Agonists Enhances Antitumor Effect in Murine Tumor Models